nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP2C9—Donepezil—Alzheimer's disease	0.156	0.373	CbGbCtD
Bexarotene—CYP3A4—Rivastigmine—Alzheimer's disease	0.114	0.271	CbGbCtD
Bexarotene—CYP3A4—Donepezil—Alzheimer's disease	0.0909	0.217	CbGbCtD
Bexarotene—CYP3A4—Galantamine—Alzheimer's disease	0.0585	0.14	CbGbCtD
Bexarotene—RXRA—forebrain—Alzheimer's disease	0.00524	0.137	CbGeAlD
Bexarotene—RXRA—telencephalon—Alzheimer's disease	0.00482	0.126	CbGeAlD
Bexarotene—RXRB—telencephalon—Alzheimer's disease	0.00398	0.104	CbGeAlD
Bexarotene—RXRA—nervous system—Alzheimer's disease	0.00285	0.0744	CbGeAlD
Bexarotene—RXRA—central nervous system—Alzheimer's disease	0.00274	0.0716	CbGeAlD
Bexarotene—RXRG—nervous system—Alzheimer's disease	0.0025	0.0653	CbGeAlD
Bexarotene—RXRG—central nervous system—Alzheimer's disease	0.00241	0.0629	CbGeAlD
Bexarotene—RXRB—nervous system—Alzheimer's disease	0.00235	0.0614	CbGeAlD
Bexarotene—RXRB—central nervous system—Alzheimer's disease	0.00226	0.0591	CbGeAlD
Bexarotene—RXRB—cerebellum—Alzheimer's disease	0.00221	0.0578	CbGeAlD
Bexarotene—RXRA—brain—Alzheimer's disease	0.00217	0.0568	CbGeAlD
Bexarotene—RXRG—brain—Alzheimer's disease	0.00191	0.0499	CbGeAlD
Bexarotene—RXRB—brain—Alzheimer's disease	0.0018	0.0469	CbGeAlD
Bexarotene—CYP3A4—nervous system—Alzheimer's disease	0.000526	0.0137	CbGeAlD
Bexarotene—CYP3A4—central nervous system—Alzheimer's disease	0.000506	0.0132	CbGeAlD
Bexarotene—Epistaxis—Memantine—Alzheimer's disease	0.000439	0.00107	CcSEcCtD
Bexarotene—Anxiety—Galantamine—Alzheimer's disease	0.000439	0.00106	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000437	0.00106	CcSEcCtD
Bexarotene—Sinusitis—Memantine—Alzheimer's disease	0.000437	0.00106	CcSEcCtD
Bexarotene—Sweating—Rivastigmine—Alzheimer's disease	0.000437	0.00106	CcSEcCtD
Bexarotene—Discomfort—Galantamine—Alzheimer's disease	0.000435	0.00106	CcSEcCtD
Bexarotene—Haematuria—Rivastigmine—Alzheimer's disease	0.000434	0.00105	CcSEcCtD
Bexarotene—Dry mouth—Galantamine—Alzheimer's disease	0.000431	0.00104	CcSEcCtD
Bexarotene—Epistaxis—Rivastigmine—Alzheimer's disease	0.00043	0.00104	CcSEcCtD
Bexarotene—Tinnitus—Donepezil—Alzheimer's disease	0.000429	0.00104	CcSEcCtD
Bexarotene—Sinusitis—Rivastigmine—Alzheimer's disease	0.000427	0.00104	CcSEcCtD
Bexarotene—Confusional state—Galantamine—Alzheimer's disease	0.000426	0.00103	CcSEcCtD
Bexarotene—Haemoglobin—Memantine—Alzheimer's disease	0.00042	0.00102	CcSEcCtD
Bexarotene—Rhinitis—Memantine—Alzheimer's disease	0.000419	0.00102	CcSEcCtD
Bexarotene—Haemorrhage—Memantine—Alzheimer's disease	0.000418	0.00101	CcSEcCtD
Bexarotene—Hypoaesthesia—Memantine—Alzheimer's disease	0.000416	0.00101	CcSEcCtD
Bexarotene—Shock—Galantamine—Alzheimer's disease	0.000415	0.00101	CcSEcCtD
Bexarotene—Pharyngitis—Memantine—Alzheimer's disease	0.000415	0.00101	CcSEcCtD
Bexarotene—Nervous system disorder—Galantamine—Alzheimer's disease	0.000414	0.001	CcSEcCtD
Bexarotene—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000413	0.001	CcSEcCtD
Bexarotene—Chills—Donepezil—Alzheimer's disease	0.000413	0.001	CcSEcCtD
Bexarotene—Urinary tract disorder—Memantine—Alzheimer's disease	0.000413	0.001	CcSEcCtD
Bexarotene—Tachycardia—Galantamine—Alzheimer's disease	0.000412	0.000999	CcSEcCtD
Bexarotene—Oedema peripheral—Memantine—Alzheimer's disease	0.000412	0.000999	CcSEcCtD
Bexarotene—Arrhythmia—Donepezil—Alzheimer's disease	0.000411	0.000998	CcSEcCtD
Bexarotene—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000411	0.000997	CcSEcCtD
Bexarotene—Connective tissue disorder—Memantine—Alzheimer's disease	0.000411	0.000997	CcSEcCtD
Bexarotene—Rhinitis—Rivastigmine—Alzheimer's disease	0.00041	0.000995	CcSEcCtD
Bexarotene—Skin disorder—Galantamine—Alzheimer's disease	0.00041	0.000995	CcSEcCtD
Bexarotene—Urethral disorder—Memantine—Alzheimer's disease	0.00041	0.000994	CcSEcCtD
Bexarotene—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000409	0.000992	CcSEcCtD
Bexarotene—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000408	0.00099	CcSEcCtD
Bexarotene—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000407	0.000987	CcSEcCtD
Bexarotene—Alopecia—Donepezil—Alzheimer's disease	0.000407	0.000987	CcSEcCtD
Bexarotene—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000406	0.000985	CcSEcCtD
Bexarotene—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000404	0.00098	CcSEcCtD
Bexarotene—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000403	0.000977	CcSEcCtD
Bexarotene—Anorexia—Galantamine—Alzheimer's disease	0.000402	0.000976	CcSEcCtD
Bexarotene—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000402	0.000975	CcSEcCtD
Bexarotene—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000401	0.000973	CcSEcCtD
Bexarotene—Erythema—Donepezil—Alzheimer's disease	0.000401	0.000972	CcSEcCtD
Bexarotene—Malnutrition—Donepezil—Alzheimer's disease	0.000401	0.000972	CcSEcCtD
Bexarotene—Flatulence—Donepezil—Alzheimer's disease	0.000395	0.000958	CcSEcCtD
Bexarotene—Tension—Donepezil—Alzheimer's disease	0.000393	0.000954	CcSEcCtD
Bexarotene—Dysgeusia—Donepezil—Alzheimer's disease	0.000393	0.000952	CcSEcCtD
Bexarotene—Eye disorder—Memantine—Alzheimer's disease	0.000391	0.000948	CcSEcCtD
Bexarotene—Tinnitus—Memantine—Alzheimer's disease	0.00039	0.000946	CcSEcCtD
Bexarotene—Nervousness—Donepezil—Alzheimer's disease	0.000389	0.000944	CcSEcCtD
Bexarotene—Cardiac disorder—Memantine—Alzheimer's disease	0.000388	0.000941	CcSEcCtD
Bexarotene—Back pain—Donepezil—Alzheimer's disease	0.000388	0.000941	CcSEcCtD
Bexarotene—Muscle spasms—Donepezil—Alzheimer's disease	0.000385	0.000935	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000385	0.000933	CcSEcCtD
Bexarotene—Eye disorder—Rivastigmine—Alzheimer's disease	0.000382	0.000927	CcSEcCtD
Bexarotene—Insomnia—Galantamine—Alzheimer's disease	0.000382	0.000926	CcSEcCtD
Bexarotene—Tinnitus—Rivastigmine—Alzheimer's disease	0.000381	0.000925	CcSEcCtD
Bexarotene—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00038	0.000921	CcSEcCtD
Bexarotene—Angiopathy—Memantine—Alzheimer's disease	0.000379	0.00092	CcSEcCtD
Bexarotene—Paraesthesia—Galantamine—Alzheimer's disease	0.000379	0.00092	CcSEcCtD
Bexarotene—Somnolence—Galantamine—Alzheimer's disease	0.000375	0.00091	CcSEcCtD
Bexarotene—Chills—Memantine—Alzheimer's disease	0.000375	0.00091	CcSEcCtD
Bexarotene—Arrhythmia—Memantine—Alzheimer's disease	0.000373	0.000906	CcSEcCtD
Bexarotene—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000372	0.000902	CcSEcCtD
Bexarotene—Dyspepsia—Galantamine—Alzheimer's disease	0.000372	0.000901	CcSEcCtD
Bexarotene—Angiopathy—Rivastigmine—Alzheimer's disease	0.000371	0.0009	CcSEcCtD
Bexarotene—Anaemia—Donepezil—Alzheimer's disease	0.00037	0.000899	CcSEcCtD
Bexarotene—Alopecia—Memantine—Alzheimer's disease	0.000369	0.000896	CcSEcCtD
Bexarotene—Agitation—Donepezil—Alzheimer's disease	0.000368	0.000894	CcSEcCtD
Bexarotene—Chills—Rivastigmine—Alzheimer's disease	0.000367	0.00089	CcSEcCtD
Bexarotene—Decreased appetite—Galantamine—Alzheimer's disease	0.000367	0.00089	CcSEcCtD
Bexarotene—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000365	0.000886	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000364	0.000884	CcSEcCtD
Bexarotene—Malnutrition—Memantine—Alzheimer's disease	0.000364	0.000883	CcSEcCtD
Bexarotene—Fatigue—Galantamine—Alzheimer's disease	0.000364	0.000883	CcSEcCtD
Bexarotene—Malaise—Donepezil—Alzheimer's disease	0.000361	0.000877	CcSEcCtD
Bexarotene—Alopecia—Rivastigmine—Alzheimer's disease	0.000361	0.000877	CcSEcCtD
Bexarotene—Constipation—Galantamine—Alzheimer's disease	0.000361	0.000876	CcSEcCtD
Bexarotene—Vertigo—Donepezil—Alzheimer's disease	0.00036	0.000874	CcSEcCtD
Bexarotene—Syncope—Donepezil—Alzheimer's disease	0.000359	0.000872	CcSEcCtD
Bexarotene—Flatulence—Memantine—Alzheimer's disease	0.000359	0.00087	CcSEcCtD
Bexarotene—Tension—Memantine—Alzheimer's disease	0.000357	0.000866	CcSEcCtD
Bexarotene—Dysgeusia—Memantine—Alzheimer's disease	0.000356	0.000865	CcSEcCtD
Bexarotene—Malnutrition—Rivastigmine—Alzheimer's disease	0.000356	0.000864	CcSEcCtD
Bexarotene—Erythema—Rivastigmine—Alzheimer's disease	0.000356	0.000864	CcSEcCtD
Bexarotene—Nervousness—Memantine—Alzheimer's disease	0.000353	0.000858	CcSEcCtD
Bexarotene—Loss of consciousness—Donepezil—Alzheimer's disease	0.000352	0.000855	CcSEcCtD
Bexarotene—Back pain—Memantine—Alzheimer's disease	0.000352	0.000854	CcSEcCtD
Bexarotene—Flatulence—Rivastigmine—Alzheimer's disease	0.000351	0.000851	CcSEcCtD
Bexarotene—Cough—Donepezil—Alzheimer's disease	0.00035	0.000849	CcSEcCtD
Bexarotene—Tension—Rivastigmine—Alzheimer's disease	0.000349	0.000848	CcSEcCtD
Bexarotene—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000349	0.000846	CcSEcCtD
Bexarotene—Feeling abnormal—Galantamine—Alzheimer's disease	0.000348	0.000844	CcSEcCtD
Bexarotene—Hypertension—Donepezil—Alzheimer's disease	0.000346	0.00084	CcSEcCtD
Bexarotene—Nervousness—Rivastigmine—Alzheimer's disease	0.000346	0.000839	CcSEcCtD
Bexarotene—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000345	0.000837	CcSEcCtD
Bexarotene—Back pain—Rivastigmine—Alzheimer's disease	0.000344	0.000835	CcSEcCtD
Bexarotene—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000342	0.00083	CcSEcCtD
Bexarotene—Arthralgia—Donepezil—Alzheimer's disease	0.000341	0.000828	CcSEcCtD
Bexarotene—Myalgia—Donepezil—Alzheimer's disease	0.000341	0.000828	CcSEcCtD
Bexarotene—Chest pain—Donepezil—Alzheimer's disease	0.000341	0.000828	CcSEcCtD
Bexarotene—Anxiety—Donepezil—Alzheimer's disease	0.00034	0.000825	CcSEcCtD
Bexarotene—Ill-defined disorder—Memantine—Alzheimer's disease	0.000338	0.000819	CcSEcCtD
Bexarotene—Discomfort—Donepezil—Alzheimer's disease	0.000337	0.000818	CcSEcCtD
Bexarotene—Anaemia—Memantine—Alzheimer's disease	0.000336	0.000816	CcSEcCtD
Bexarotene—Agitation—Memantine—Alzheimer's disease	0.000334	0.000811	CcSEcCtD
Bexarotene—Dry mouth—Donepezil—Alzheimer's disease	0.000334	0.00081	CcSEcCtD
Bexarotene—Abdominal pain—Galantamine—Alzheimer's disease	0.000334	0.00081	CcSEcCtD
Bexarotene—Body temperature increased—Galantamine—Alzheimer's disease	0.000334	0.00081	CcSEcCtD
Bexarotene—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00033	0.000801	CcSEcCtD
Bexarotene—Confusional state—Donepezil—Alzheimer's disease	0.00033	0.0008	CcSEcCtD
Bexarotene—Anaemia—Rivastigmine—Alzheimer's disease	0.000329	0.000798	CcSEcCtD
Bexarotene—Malaise—Memantine—Alzheimer's disease	0.000328	0.000796	CcSEcCtD
Bexarotene—Agitation—Rivastigmine—Alzheimer's disease	0.000327	0.000794	CcSEcCtD
Bexarotene—Oedema—Donepezil—Alzheimer's disease	0.000327	0.000794	CcSEcCtD
Bexarotene—Vertigo—Memantine—Alzheimer's disease	0.000327	0.000793	CcSEcCtD
Bexarotene—Syncope—Memantine—Alzheimer's disease	0.000326	0.000792	CcSEcCtD
Bexarotene—Leukopenia—Memantine—Alzheimer's disease	0.000326	0.00079	CcSEcCtD
Bexarotene—Infection—Donepezil—Alzheimer's disease	0.000325	0.000788	CcSEcCtD
Bexarotene—Shock—Donepezil—Alzheimer's disease	0.000322	0.000781	CcSEcCtD
Bexarotene—Palpitations—Memantine—Alzheimer's disease	0.000322	0.00078	CcSEcCtD
Bexarotene—Malaise—Rivastigmine—Alzheimer's disease	0.000321	0.000779	CcSEcCtD
Bexarotene—Nervous system disorder—Donepezil—Alzheimer's disease	0.000321	0.000778	CcSEcCtD
Bexarotene—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00032	0.000777	CcSEcCtD
Bexarotene—Vertigo—Rivastigmine—Alzheimer's disease	0.00032	0.000776	CcSEcCtD
Bexarotene—Loss of consciousness—Memantine—Alzheimer's disease	0.00032	0.000776	CcSEcCtD
Bexarotene—Syncope—Rivastigmine—Alzheimer's disease	0.000319	0.000775	CcSEcCtD
Bexarotene—Cough—Memantine—Alzheimer's disease	0.000318	0.00077	CcSEcCtD
Bexarotene—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000316	0.000767	CcSEcCtD
Bexarotene—Palpitations—Rivastigmine—Alzheimer's disease	0.000315	0.000763	CcSEcCtD
Bexarotene—Hypertension—Memantine—Alzheimer's disease	0.000314	0.000762	CcSEcCtD
Bexarotene—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000313	0.000759	CcSEcCtD
Bexarotene—Anorexia—Donepezil—Alzheimer's disease	0.000312	0.000756	CcSEcCtD
Bexarotene—Hypersensitivity—Galantamine—Alzheimer's disease	0.000311	0.000754	CcSEcCtD
Bexarotene—Cough—Rivastigmine—Alzheimer's disease	0.000311	0.000754	CcSEcCtD
Bexarotene—Arthralgia—Memantine—Alzheimer's disease	0.00031	0.000752	CcSEcCtD
Bexarotene—Myalgia—Memantine—Alzheimer's disease	0.00031	0.000752	CcSEcCtD
Bexarotene—Chest pain—Memantine—Alzheimer's disease	0.00031	0.000752	CcSEcCtD
Bexarotene—Anxiety—Memantine—Alzheimer's disease	0.000309	0.000749	CcSEcCtD
Bexarotene—Hypertension—Rivastigmine—Alzheimer's disease	0.000307	0.000746	CcSEcCtD
Bexarotene—Discomfort—Memantine—Alzheimer's disease	0.000306	0.000743	CcSEcCtD
Bexarotene—Arthralgia—Rivastigmine—Alzheimer's disease	0.000303	0.000735	CcSEcCtD
Bexarotene—Chest pain—Rivastigmine—Alzheimer's disease	0.000303	0.000735	CcSEcCtD
Bexarotene—Myalgia—Rivastigmine—Alzheimer's disease	0.000303	0.000735	CcSEcCtD
Bexarotene—Dry mouth—Memantine—Alzheimer's disease	0.000303	0.000735	CcSEcCtD
Bexarotene—Asthenia—Galantamine—Alzheimer's disease	0.000303	0.000735	CcSEcCtD
Bexarotene—Anxiety—Rivastigmine—Alzheimer's disease	0.000302	0.000733	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000301	0.00073	CcSEcCtD
Bexarotene—Confusional state—Memantine—Alzheimer's disease	0.0003	0.000727	CcSEcCtD
Bexarotene—Discomfort—Rivastigmine—Alzheimer's disease	0.000299	0.000727	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000298	0.000723	CcSEcCtD
Bexarotene—Oedema—Memantine—Alzheimer's disease	0.000297	0.000721	CcSEcCtD
Bexarotene—Dry mouth—Rivastigmine—Alzheimer's disease	0.000296	0.000719	CcSEcCtD
Bexarotene—Insomnia—Donepezil—Alzheimer's disease	0.000296	0.000718	CcSEcCtD
Bexarotene—Infection—Memantine—Alzheimer's disease	0.000295	0.000716	CcSEcCtD
Bexarotene—Paraesthesia—Donepezil—Alzheimer's disease	0.000294	0.000713	CcSEcCtD
Bexarotene—Confusional state—Rivastigmine—Alzheimer's disease	0.000293	0.000711	CcSEcCtD
Bexarotene—Shock—Memantine—Alzheimer's disease	0.000292	0.000709	CcSEcCtD
Bexarotene—Dyspnoea—Donepezil—Alzheimer's disease	0.000292	0.000708	CcSEcCtD
Bexarotene—Nervous system disorder—Memantine—Alzheimer's disease	0.000291	0.000707	CcSEcCtD
Bexarotene—Somnolence—Donepezil—Alzheimer's disease	0.000291	0.000706	CcSEcCtD
Bexarotene—Thrombocytopenia—Memantine—Alzheimer's disease	0.000291	0.000706	CcSEcCtD
Bexarotene—Oedema—Rivastigmine—Alzheimer's disease	0.000291	0.000705	CcSEcCtD
Bexarotene—Tachycardia—Memantine—Alzheimer's disease	0.00029	0.000703	CcSEcCtD
Bexarotene—Diarrhoea—Galantamine—Alzheimer's disease	0.000289	0.000701	CcSEcCtD
Bexarotene—Infection—Rivastigmine—Alzheimer's disease	0.000289	0.0007	CcSEcCtD
Bexarotene—Skin disorder—Memantine—Alzheimer's disease	0.000289	0.0007	CcSEcCtD
Bexarotene—Dyspepsia—Donepezil—Alzheimer's disease	0.000288	0.000699	CcSEcCtD
Bexarotene—Hyperhidrosis—Memantine—Alzheimer's disease	0.000287	0.000697	CcSEcCtD
Bexarotene—Shock—Rivastigmine—Alzheimer's disease	0.000286	0.000694	CcSEcCtD
Bexarotene—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000285	0.000691	CcSEcCtD
Bexarotene—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000285	0.00069	CcSEcCtD
Bexarotene—Decreased appetite—Donepezil—Alzheimer's disease	0.000284	0.00069	CcSEcCtD
Bexarotene—Tachycardia—Rivastigmine—Alzheimer's disease	0.000284	0.000688	CcSEcCtD
Bexarotene—Anorexia—Memantine—Alzheimer's disease	0.000283	0.000687	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000282	0.000685	CcSEcCtD
Bexarotene—Skin disorder—Rivastigmine—Alzheimer's disease	0.000282	0.000685	CcSEcCtD
Bexarotene—Fatigue—Donepezil—Alzheimer's disease	0.000282	0.000684	CcSEcCtD
Bexarotene—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000281	0.000681	CcSEcCtD
Bexarotene—Constipation—Donepezil—Alzheimer's disease	0.00028	0.000679	CcSEcCtD
Bexarotene—Pain—Donepezil—Alzheimer's disease	0.00028	0.000679	CcSEcCtD
Bexarotene—Dizziness—Galantamine—Alzheimer's disease	0.000279	0.000677	CcSEcCtD
Bexarotene—Anorexia—Rivastigmine—Alzheimer's disease	0.000277	0.000672	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000271	0.000657	CcSEcCtD
Bexarotene—Feeling abnormal—Donepezil—Alzheimer's disease	0.00027	0.000654	CcSEcCtD
Bexarotene—Insomnia—Memantine—Alzheimer's disease	0.000269	0.000652	CcSEcCtD
Bexarotene—Vomiting—Galantamine—Alzheimer's disease	0.000268	0.000651	CcSEcCtD
Bexarotene—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000268	0.000649	CcSEcCtD
Bexarotene—Paraesthesia—Memantine—Alzheimer's disease	0.000267	0.000647	CcSEcCtD
Bexarotene—Rash—Galantamine—Alzheimer's disease	0.000266	0.000646	CcSEcCtD
Bexarotene—Dermatitis—Galantamine—Alzheimer's disease	0.000266	0.000645	CcSEcCtD
Bexarotene—Dyspnoea—Memantine—Alzheimer's disease	0.000265	0.000642	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000265	0.000642	CcSEcCtD
Bexarotene—Headache—Galantamine—Alzheimer's disease	0.000264	0.000642	CcSEcCtD
Bexarotene—Somnolence—Memantine—Alzheimer's disease	0.000264	0.000641	CcSEcCtD
Bexarotene—Insomnia—Rivastigmine—Alzheimer's disease	0.000263	0.000638	CcSEcCtD
Bexarotene—Dyspepsia—Memantine—Alzheimer's disease	0.000261	0.000634	CcSEcCtD
Bexarotene—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000261	0.000633	CcSEcCtD
Bexarotene—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000259	0.000628	CcSEcCtD
Bexarotene—Body temperature increased—Donepezil—Alzheimer's disease	0.000259	0.000627	CcSEcCtD
Bexarotene—Abdominal pain—Donepezil—Alzheimer's disease	0.000259	0.000627	CcSEcCtD
Bexarotene—Somnolence—Rivastigmine—Alzheimer's disease	0.000258	0.000627	CcSEcCtD
Bexarotene—Decreased appetite—Memantine—Alzheimer's disease	0.000258	0.000626	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000256	0.000622	CcSEcCtD
Bexarotene—Fatigue—Memantine—Alzheimer's disease	0.000256	0.000621	CcSEcCtD
Bexarotene—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000256	0.000621	CcSEcCtD
Bexarotene—Pain—Memantine—Alzheimer's disease	0.000254	0.000616	CcSEcCtD
Bexarotene—Constipation—Memantine—Alzheimer's disease	0.000254	0.000616	CcSEcCtD
Bexarotene—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000253	0.000613	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000251	0.000609	CcSEcCtD
Bexarotene—Nausea—Galantamine—Alzheimer's disease	0.000251	0.000608	CcSEcCtD
Bexarotene—Fatigue—Rivastigmine—Alzheimer's disease	0.000251	0.000608	CcSEcCtD
Bexarotene—Pain—Rivastigmine—Alzheimer's disease	0.000248	0.000603	CcSEcCtD
Bexarotene—Constipation—Rivastigmine—Alzheimer's disease	0.000248	0.000603	CcSEcCtD
Bexarotene—Feeling abnormal—Memantine—Alzheimer's disease	0.000245	0.000594	CcSEcCtD
Bexarotene—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000243	0.000589	CcSEcCtD
Bexarotene—Hypersensitivity—Donepezil—Alzheimer's disease	0.000241	0.000585	CcSEcCtD
Bexarotene—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000239	0.000581	CcSEcCtD
Bexarotene—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000238	0.000576	CcSEcCtD
Bexarotene—Abdominal pain—Memantine—Alzheimer's disease	0.000235	0.00057	CcSEcCtD
Bexarotene—Body temperature increased—Memantine—Alzheimer's disease	0.000235	0.00057	CcSEcCtD
Bexarotene—Asthenia—Donepezil—Alzheimer's disease	0.000235	0.000569	CcSEcCtD
Bexarotene—RXRA—NRF2 pathway—HMOX1—Alzheimer's disease	0.000234	0.0018	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—MEF2C—Alzheimer's disease	0.000233	0.00179	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP46A1—Alzheimer's disease	0.000232	0.00178	CbGpPWpGaD
Bexarotene—Pruritus—Donepezil—Alzheimer's disease	0.000231	0.000561	CcSEcCtD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—Alzheimer's disease	0.000231	0.00177	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—EPHA1—Alzheimer's disease	0.00023	0.00177	CbGpPWpGaD
Bexarotene—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00023	0.000557	CcSEcCtD
Bexarotene—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00023	0.000557	CcSEcCtD
Bexarotene—RXRG—Gene Expression—TFAM—Alzheimer's disease	0.00023	0.00176	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000229	0.00176	CbGpPWpGaD
Bexarotene—Diarrhoea—Donepezil—Alzheimer's disease	0.000224	0.000543	CcSEcCtD
Bexarotene—RXRA—Retinoic acid receptors-mediated signaling—AKT1—Alzheimer's disease	0.000219	0.00168	CbGpPWpGaD
Bexarotene—Hypersensitivity—Memantine—Alzheimer's disease	0.000219	0.000531	CcSEcCtD
Bexarotene—Dizziness—Donepezil—Alzheimer's disease	0.000216	0.000525	CcSEcCtD
Bexarotene—RXRB—Gene Expression—TFAM—Alzheimer's disease	0.000216	0.00166	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000216	0.00166	CbGpPWpGaD
Bexarotene—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000214	0.000519	CcSEcCtD
Bexarotene—RXRA—Organelle biogenesis and maintenance—MEF2C—Alzheimer's disease	0.000213	0.00164	CbGpPWpGaD
Bexarotene—Asthenia—Memantine—Alzheimer's disease	0.000213	0.000517	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—CDK5—Alzheimer's disease	0.000211	0.00162	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—AGER—Alzheimer's disease	0.00021	0.00162	CbGpPWpGaD
Bexarotene—Pruritus—Memantine—Alzheimer's disease	0.00021	0.00051	CcSEcCtD
Bexarotene—Asthenia—Rivastigmine—Alzheimer's disease	0.000208	0.000506	CcSEcCtD
Bexarotene—Vomiting—Donepezil—Alzheimer's disease	0.000208	0.000505	CcSEcCtD
Bexarotene—Rash—Donepezil—Alzheimer's disease	0.000206	0.0005	CcSEcCtD
Bexarotene—Dermatitis—Donepezil—Alzheimer's disease	0.000206	0.0005	CcSEcCtD
Bexarotene—Pruritus—Rivastigmine—Alzheimer's disease	0.000206	0.000499	CcSEcCtD
Bexarotene—Headache—Donepezil—Alzheimer's disease	0.000205	0.000497	CcSEcCtD
Bexarotene—Diarrhoea—Memantine—Alzheimer's disease	0.000203	0.000493	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000201	0.00154	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TGFB1—Alzheimer's disease	0.000199	0.00153	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—Alzheimer's disease	0.000199	0.00153	CbGpPWpGaD
Bexarotene—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000199	0.000482	CcSEcCtD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000198	0.00152	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—LEP—Alzheimer's disease	0.000197	0.00151	CbGpPWpGaD
Bexarotene—Dizziness—Memantine—Alzheimer's disease	0.000196	0.000477	CcSEcCtD
Bexarotene—RXRA—PPARA activates gene expression—PPARG—Alzheimer's disease	0.000196	0.00151	CbGpPWpGaD
Bexarotene—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000195	0.0015	CbGpPWpGaD
Bexarotene—Nausea—Donepezil—Alzheimer's disease	0.000194	0.000471	CcSEcCtD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000194	0.00149	CbGpPWpGaD
Bexarotene—Dizziness—Rivastigmine—Alzheimer's disease	0.000192	0.000466	CcSEcCtD
Bexarotene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Alzheimer's disease	0.000192	0.00147	CbGpPWpGaD
Bexarotene—Vomiting—Memantine—Alzheimer's disease	0.000189	0.000458	CcSEcCtD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000187	0.00144	CbGpPWpGaD
Bexarotene—Rash—Memantine—Alzheimer's disease	0.000187	0.000454	CcSEcCtD
Bexarotene—Dermatitis—Memantine—Alzheimer's disease	0.000187	0.000454	CcSEcCtD
Bexarotene—Headache—Memantine—Alzheimer's disease	0.000186	0.000451	CcSEcCtD
Bexarotene—RXRG—Adipogenesis—TNF—Alzheimer's disease	0.000186	0.00143	CbGpPWpGaD
Bexarotene—Vomiting—Rivastigmine—Alzheimer's disease	0.000185	0.000448	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000184	0.00142	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PSENEN—Alzheimer's disease	0.000184	0.00141	CbGpPWpGaD
Bexarotene—Rash—Rivastigmine—Alzheimer's disease	0.000183	0.000444	CcSEcCtD
Bexarotene—Dermatitis—Rivastigmine—Alzheimer's disease	0.000183	0.000444	CcSEcCtD
Bexarotene—Headache—Rivastigmine—Alzheimer's disease	0.000182	0.000442	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—APH1A—Alzheimer's disease	0.000182	0.00139	CbGpPWpGaD
Bexarotene—RXRA—Organelle biogenesis and maintenance—CALM1—Alzheimer's disease	0.000181	0.00139	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NCSTN—Alzheimer's disease	0.000177	0.00136	CbGpPWpGaD
Bexarotene—Nausea—Memantine—Alzheimer's disease	0.000176	0.000428	CcSEcCtD
Bexarotene—RXRA—Gene Expression—PHF1—Alzheimer's disease	0.000175	0.00134	CbGpPWpGaD
Bexarotene—Nausea—Rivastigmine—Alzheimer's disease	0.000173	0.000419	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000172	0.00132	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—PPARG—Alzheimer's disease	0.000172	0.00132	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000172	0.00132	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—CREB1—Alzheimer's disease	0.000169	0.0013	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—INS—Alzheimer's disease	0.000168	0.00129	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—IGF1—Alzheimer's disease	0.000163	0.00125	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—DHCR24—Alzheimer's disease	0.00016	0.00123	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—Alzheimer's disease	0.000159	0.00122	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000158	0.00121	CbGpPWpGaD
Bexarotene—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000156	0.0012	CbGpPWpGaD
Bexarotene—RXRA—Organelle biogenesis and maintenance—CREB1—Alzheimer's disease	0.000155	0.00119	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000153	0.00118	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000151	0.00116	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—IL6—Alzheimer's disease	0.00015	0.00115	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000149	0.00114	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PRNP—Alzheimer's disease	0.000149	0.00114	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—Alzheimer's disease	0.000148	0.00114	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PSEN2—Alzheimer's disease	0.000144	0.0011	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.00014	0.00108	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	0.000139	0.00106	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—Alzheimer's disease	0.000139	0.00106	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.000138	0.00106	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—EIF2S1—Alzheimer's disease	0.000138	0.00106	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CA4—Alzheimer's disease	0.000136	0.00104	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000135	0.00104	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000134	0.00103	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000133	0.00102	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Alzheimer's disease	0.000132	0.00102	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.000132	0.00101	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IAPP—Alzheimer's disease	0.000132	0.00101	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000131	0.001	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—EIF2S1—Alzheimer's disease	0.00013	0.000997	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000128	0.000983	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.000128	0.000982	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GAPDHS—Alzheimer's disease	0.000128	0.00098	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000127	0.000978	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000126	0.000968	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.000124	0.000955	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000124	0.000949	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ATP5A1—Alzheimer's disease	0.000121	0.000929	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.00012	0.000923	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.00012	0.000919	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PLD3—Alzheimer's disease	0.000115	0.000886	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000115	0.000886	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000114	0.000876	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—TFAM—Alzheimer's disease	0.000112	0.000863	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HSD17B10—Alzheimer's disease	0.000111	0.000849	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—DLG4—Alzheimer's disease	0.00011	0.000843	CbGpPWpGaD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000108	0.000831	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000108	0.00083	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—GRIN2B—Alzheimer's disease	0.000107	0.000824	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000107	0.000823	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP46A1—Alzheimer's disease	0.000106	0.000818	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	0.000105	0.000807	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	0.000104	0.000802	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	0.000103	0.000791	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ND1—Alzheimer's disease	0.000103	0.00079	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000102	0.000781	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000101	0.000772	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	9.92e-05	0.000762	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TGFB1—Alzheimer's disease	9.76e-05	0.000749	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—ADAM10—Alzheimer's disease	9.68e-05	0.000743	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	9.67e-05	0.000743	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	9.21e-05	0.000707	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	9.19e-05	0.000706	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	9.15e-05	0.000702	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TNF—Alzheimer's disease	9.11e-05	0.0007	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	8.93e-05	0.000685	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—TGFB1—Alzheimer's disease	8.89e-05	0.000683	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PPARGC1A—Alzheimer's disease	8.87e-05	0.000681	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	8.46e-05	0.00065	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—LPL—Alzheimer's disease	8.08e-05	0.00062	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MEF2C—Alzheimer's disease	8.01e-05	0.000615	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	7.92e-05	0.000608	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	7.82e-05	0.0006	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	7.5e-05	0.000576	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—IL6—Alzheimer's disease	7.35e-05	0.000565	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	7.21e-05	0.000554	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	7.17e-05	0.000551	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	6.93e-05	0.000532	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—ESR1—Alzheimer's disease	6.87e-05	0.000527	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	6.8e-05	0.000522	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—LEP—Alzheimer's disease	6.77e-05	0.00052	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—EIF2S1—Alzheimer's disease	6.77e-05	0.00052	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—ESR1—Alzheimer's disease	6.75e-05	0.000518	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	6.7e-05	0.000515	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	6.7e-05	0.000514	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	6.64e-05	0.00051	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TPI1—Alzheimer's disease	6.63e-05	0.000509	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CHAT—Alzheimer's disease	6.63e-05	0.000509	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—NOTCH1—Alzheimer's disease	6.52e-05	0.000501	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—MAOB—Alzheimer's disease	6.35e-05	0.000488	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—ESR1—Alzheimer's disease	6.34e-05	0.000487	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—PPARG—Alzheimer's disease	6.27e-05	0.000481	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NOTCH1—Alzheimer's disease	6.25e-05	0.00048	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PPARG—Alzheimer's disease	6.16e-05	0.000473	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—NOTCH1—Alzheimer's disease	6.13e-05	0.000471	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GAPDH—Alzheimer's disease	6.12e-05	0.00047	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	6.05e-05	0.000464	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.99e-05	0.00046	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	5.96e-05	0.000457	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—A2M—Alzheimer's disease	5.91e-05	0.000454	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	5.91e-05	0.000453	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PPARG—Alzheimer's disease	5.9e-05	0.000453	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—GSK3B—Alzheimer's disease	5.86e-05	0.00045	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CREB1—Alzheimer's disease	5.82e-05	0.000447	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PPARG—Alzheimer's disease	5.79e-05	0.000444	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—INS—Alzheimer's disease	5.78e-05	0.000444	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	5.56e-05	0.000427	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.27e-05	0.000404	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ACHE—Alzheimer's disease	5.14e-05	0.000395	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—INPP5D—Alzheimer's disease	5.08e-05	0.00039	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CA4—Alzheimer's disease	5.07e-05	0.000389	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	4.99e-05	0.000383	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.95e-05	0.00038	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS1—Alzheimer's disease	4.82e-05	0.00037	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ENO1—Alzheimer's disease	4.82e-05	0.00037	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	4.76e-05	0.000366	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP2D6—Alzheimer's disease	4.72e-05	0.000363	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	4.52e-05	0.000347	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—BCHE—Alzheimer's disease	4.48e-05	0.000344	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLD3—Alzheimer's disease	4.31e-05	0.000331	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.31e-05	0.000331	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.26e-05	0.000327	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PLCB1—Alzheimer's disease	4.22e-05	0.000324	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.14e-05	0.000318	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	4.13e-05	0.000317	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ABCA1—Alzheimer's disease	4.09e-05	0.000314	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	4.04e-05	0.00031	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	3.98e-05	0.000305	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	3.93e-05	0.000302	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ND1—Alzheimer's disease	3.84e-05	0.000295	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.75e-05	0.000288	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—Alzheimer's disease	3.65e-05	0.000281	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARGC1A—Alzheimer's disease	3.53e-05	0.000271	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HMOX1—Alzheimer's disease	3.51e-05	0.00027	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.43e-05	0.000264	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—Alzheimer's disease	3.35e-05	0.000258	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CA4—Alzheimer's disease	3.34e-05	0.000257	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ESR1—Alzheimer's disease	3.31e-05	0.000254	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LPL—Alzheimer's disease	3.21e-05	0.000247	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NOTCH1—Alzheimer's disease	3.2e-05	0.000245	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	3.14e-05	0.000241	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—Alzheimer's disease	3.13e-05	0.00024	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARG—Alzheimer's disease	3.02e-05	0.000232	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.98e-05	0.000229	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.96e-05	0.000227	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—MTHFR—Alzheimer's disease	2.89e-05	0.000222	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.84e-05	0.000218	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.72e-05	0.000209	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CALM1—Alzheimer's disease	2.7e-05	0.000207	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.69e-05	0.000207	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOE—Alzheimer's disease	2.69e-05	0.000207	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CAV1—Alzheimer's disease	2.67e-05	0.000205	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.62e-05	0.000201	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.53e-05	0.000194	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—Alzheimer's disease	2.53e-05	0.000194	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CHAT—Alzheimer's disease	2.47e-05	0.00019	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TPI1—Alzheimer's disease	2.47e-05	0.00019	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—AKT1—Alzheimer's disease	2.43e-05	0.000187	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MAOB—Alzheimer's disease	2.37e-05	0.000182	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARG—Alzheimer's disease	2.35e-05	0.00018	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT1—Alzheimer's disease	2.33e-05	0.000179	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—INS—Alzheimer's disease	2.3e-05	0.000177	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—AKT1—Alzheimer's disease	2.29e-05	0.000176	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	2.28e-05	0.000175	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.26e-05	0.000173	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.24e-05	0.000172	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—A2M—Alzheimer's disease	2.21e-05	0.000169	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NOS3—Alzheimer's disease	2.02e-05	0.000155	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.97e-05	0.000151	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ACHE—Alzheimer's disease	1.92e-05	0.000147	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	1.9e-05	0.000146	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—Alzheimer's disease	1.85e-05	0.000142	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ENO1—Alzheimer's disease	1.8e-05	0.000138	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	1.8e-05	0.000138	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	1.76e-05	0.000135	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—BCHE—Alzheimer's disease	1.67e-05	0.000128	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.63e-05	0.000125	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.63e-05	0.000125	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	1.58e-05	0.000121	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.56e-05	0.00012	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.55e-05	0.000119	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	1.53e-05	0.000117	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.51e-05	0.000116	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.45e-05	0.000112	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	1.32e-05	0.000101	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	1.31e-05	0.000101	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.27e-05	9.71e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.25e-05	9.6e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LPL—Alzheimer's disease	1.2e-05	9.21e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—AKT1—Alzheimer's disease	1.19e-05	9.16e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.19e-05	9.1e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.19e-05	9.1e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.16e-05	8.93e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.1e-05	8.46e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.08e-05	8.29e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.04e-05	7.99e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.01e-05	7.75e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.01e-05	7.74e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.01e-05	7.72e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CAV1—Alzheimer's disease	9.96e-06	7.65e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKT1—Alzheimer's disease	9.27e-06	7.12e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARG—Alzheimer's disease	8.76e-06	6.72e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	8.69e-06	6.67e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	8.65e-06	6.64e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—INS—Alzheimer's disease	8.59e-06	6.59e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LPL—Alzheimer's disease	7.91e-06	6.07e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NOS3—Alzheimer's disease	7.53e-06	5.78e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	7.12e-06	5.47e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	6.89e-06	5.29e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CALM1—Alzheimer's disease	6.65e-06	5.11e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOE—Alzheimer's disease	6.63e-06	5.09e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CAV1—Alzheimer's disease	6.57e-06	5.04e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARG—Alzheimer's disease	5.78e-06	4.43e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—INS—Alzheimer's disease	5.66e-06	4.35e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NOS3—Alzheimer's disease	4.97e-06	3.81e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	4.54e-06	3.49e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKT1—Alzheimer's disease	3.46e-06	2.66e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.28e-06	1.75e-05	CbGpPWpGaD
